MX9301060A - Derivados de azucar de macrolidos. - Google Patents

Derivados de azucar de macrolidos.

Info

Publication number
MX9301060A
MX9301060A MX9301060A MX9301060A MX9301060A MX 9301060 A MX9301060 A MX 9301060A MX 9301060 A MX9301060 A MX 9301060A MX 9301060 A MX9301060 A MX 9301060A MX 9301060 A MX9301060 A MX 9301060A
Authority
MX
Mexico
Prior art keywords
pct
macrolides
sugar derivatives
sec
date
Prior art date
Application number
MX9301060A
Other languages
English (en)
Inventor
Kevin Koch
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MX9301060A publication Critical patent/MX9301060A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Esta invención se refiere a nuevos compuestos químicos que son útiles en el campo de la ciencia médica. Más concretamente, se refiere a nuevos compuestos químicos que son útiles para su administración aun mamífero, particularmente el hombre, como agentes inmunosupresores. Estos nuevos agentes macrólidos son nuevos compuestos de esta invención que encontrarán especial utilidad en la prevención o tratamiento del rechazo de injertos posterior a la cirugía de transplante de piel u órganos y en la prevención o tratamiento de enfermedades autoinmunes tales como la artritis reumatoide y la psoriasis.
MX9301060A 1992-03-02 1993-02-26 Derivados de azucar de macrolidos. MX9301060A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84433192A 1992-03-02 1992-03-02

Publications (1)

Publication Number Publication Date
MX9301060A true MX9301060A (es) 1993-09-01

Family

ID=25292419

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301060A MX9301060A (es) 1992-03-02 1993-02-26 Derivados de azucar de macrolidos.

Country Status (14)

Country Link
US (1) US5747465A (es)
EP (1) EP0629209B1 (es)
JP (1) JP2563080B2 (es)
AT (1) ATE153027T1 (es)
AU (1) AU3586293A (es)
CA (1) CA2131372C (es)
DE (1) DE69310721T2 (es)
DK (1) DK0629209T3 (es)
ES (1) ES2102642T3 (es)
FI (1) FI107535B (es)
GR (1) GR3024048T3 (es)
IL (1) IL104817A0 (es)
MX (1) MX9301060A (es)
WO (1) WO1993018050A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP584198A0 (en) * 1998-09-14 1998-10-08 Fujisawa Pharmaceutical Co., Ltd. New use
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
JP2007519758A (ja) * 2004-12-01 2007-07-19 テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ 結晶マクロライドの生成方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1467383A (en) * 1974-06-12 1977-03-16 Farmaceutici Italia Daunomycin analogues
US4894366A (en) * 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
AU630866B2 (en) * 1987-12-09 1992-11-12 Fisons Plc Macrocyclic compounds
JPH05504944A (ja) * 1989-08-18 1993-07-29 藤沢薬品工業株式会社 巨大環式化合物
IE904050A1 (en) * 1989-11-13 1991-05-22 Merck & Co Inc Aminomacrolides and derivatives having immunosuppressive¹activity
EP0466365A3 (en) * 1990-07-03 1992-04-15 Merck & Co. Inc. Novel immunosuppressant fermentation products of a microorganism

Also Published As

Publication number Publication date
AU3586293A (en) 1993-10-05
FI944017A0 (fi) 1994-09-01
FI944017A (fi) 1994-09-01
US5747465A (en) 1998-05-05
ES2102642T3 (es) 1997-08-01
JP2563080B2 (ja) 1996-12-11
CA2131372A1 (en) 1993-09-16
FI107535B (fi) 2001-08-31
IL104817A0 (en) 1993-06-10
EP0629209A1 (en) 1994-12-21
EP0629209B1 (en) 1997-05-14
WO1993018050A1 (en) 1993-09-16
CA2131372C (en) 1998-07-14
DE69310721D1 (de) 1997-06-19
JPH07500352A (ja) 1995-01-12
DK0629209T3 (da) 1997-10-13
ATE153027T1 (de) 1997-05-15
GR3024048T3 (en) 1997-10-31
DE69310721T2 (de) 1997-09-04

Similar Documents

Publication Publication Date Title
DE69622031D1 (de) INDOLDERIVATE ALS cGMP-PDE INHIBITOREN
FR2696176B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
ZA9610543B (en) Compounds and compositions for reducing blood glucose and/or inhibiting the activity of CGRP.
IS5198A (is) Ný efnasambönd
FR2708606B1 (fr) Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant.
FR2700167B1 (fr) Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
FI944014A (fi) Makrolidien desosaminojohdannaiset immuunivastetta heikentävinä aineina ja sieniä vastustavina aineina
NO904901D0 (no) N-substituerte derivater av 3r,4r-etyl-((1-metyl-1h-imidazol-5-yl)metyl) -2-pyrrolidinon.
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
DK0686155T3 (da) Xanthinderivater som adenosin A1-receptor-antagonister
ES2102642T3 (es) Derivados azucares de macrolidos.
FR2696177B1 (fr) Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
BG102404A (en) The application of flupirtin for the prevention and treatment of diseases related to impairement of the haematopoeic cellular system
AU7101994A (en) Immunomodulatory, anti-inflammatory, and anti-proliferative compounds: 5,6-dideoxy, 5-amino derivatives of idose and 6-deoxy, 6-amino derivatives of glucose
NO984651D0 (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
DE69012742D1 (de) Azolderivate und fungizide Medikamente, diese als wirkende Komponente enthaltend.
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
FR2697253B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
MA22788A1 (fr) Preparation de dienes staeroidiens substitues.
FR2699534B1 (fr) Dérivés de alpha-thiényl-pipéridine-1-éthanol, leur préparation et leur application en thérapeutique.
FR2703355B1 (fr) Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique.
UA6640A (uk) Спосіб прогнозування загострення супутнього захворювання при активізації основної патології